| Abstract: | The Millon Clinical Multiaxial Inventory (MCMI) has always known for its adventages such, as possessing the foundation of theories of personality, easy to operate, short conducting time, providing various information, plentiful studies on validity, and available in cross-culture. These features make it practically suitible for the clinical environment in our country. Therefore, the main purpose of this study was to explore the application of The Chinese version of MCMI-III(CMCMI-III) in Taiwan.The study was divided as two pretrial and formal trial. Researchers recruited 50 subjects of “ healthy group” and 101 subjects of “mental illness group” in both pretrial and formal trial stage. All of them must take the tests of CMCMI-III, Basic Personality Inventory (BPI), Beck Depression Inventory–II (BDI-II), Beck Anxiety Inventory (BAI), and the Health, Personality, and Habit Test (HPH) in order, the “healthy group” must take the CMCMI-III test again after at least two weeks. The analys data of CMCMI-III showed great internal consistency (average Cronbach’s α = .71) and test-retest reliability (average r = .65). Additionally, there were five sub-scales of clinical syndromes (Anxiety、Bipolar: Manic、Dysthymia、Thought Disorder、Major Depression) and nine sub-scales of personality disorders (Schizoid、Avoidant、Depressive、Dependent、Narcissistic、Antisocial、Schizotypal、Borderline、Paranoid) that were significantly correlated with the construct corresponding scales of the criterion-referenced test (i.e., BPI, BDI-II, BAI, HPH). It symbolized the construct validity of the 14 scales were proven domestically, meanwhile it also provided an initial supportive evidence for using the CMCMI-III rationally in Taiwan This study supplied as the reference for related-topic researchers in the future. |
